Innovative Technologies for Cancer-Relevant Biospecimen Science (R21)

The summary for the Innovative Technologies for Cancer-Relevant Biospecimen Science (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovative Technologies for Cancer-Relevant Biospecimen Science (R21): This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects on the inception and early-stage development of technologies that address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and storage of cancer-relevant biospecimens. The overall goal is to support the development of highly innovative technologies capable of interrogating and/or maximizing the quality and utility of biospecimens or samples derived from those biospecimens for downstream analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to assess sample quality, preserve/protect sample integrity, and establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to potentially accelerate and/or enhance research in cancer biology, early detection, screening, clinical diagnosis, treatment, epidemiology, and cancer health disparities, by reducing pre-analytical variations that affect biospecimen sample quality.

This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
Federal Grant Title: Innovative Technologies for Cancer-Relevant Biospecimen Science (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-15-004
Type of Funding: Grant
CFDA Numbers: 93.394
CFDA Descriptions: Cancer Detection and Diagnosis Research
Current Application Deadline: Sep 22, 2015
Original Application Deadline: Sep 22, 2015
Posted Date: Jan 8, 2015
Creation Date: Jan 8, 2015
Archive Date: Oct 23, 2015
Total Program Funding: $1,200,000
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award: none
Expected Number of Awards: 5
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Private institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
County governments
Native American tribal governments (Federally recognized)
City or township governments
Public and State controlled institutions of higher education
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
For profit organizations other than small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-004.html
Grant Announcement Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...
Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Resear...
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Researc...
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Researc...
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Researc...
Image-Guided Cancer Interventions (STTR [R41/R42])
An SBIR Initiative for Image-Guided Cancer Interventions (R43/R44)
In Vivo Cancer Imaging Exploratory/Developmental Grants
More Grants from the National Institutes of Health
NIA Program Project Applications (P01 Clinical Trial Optional)
Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional)
Specialized Alcohol Research Centers (P50 Clinical trial Optional)
Population Dynamics Centers Research Infrastructure Program FY 2020 (P2C Clinical Trial No...
Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Cl...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com